New trends in the treatment of Diabetes

dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDepartment Of Pharmacology And Pharmacotherapyhu_HU
dc.contributor.authorAfful, Ewurakua Kotaaba
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.opponentdeptKenézy Kórház Aneszteziológiai és Intenziv Therápiás Osztályhu_HU
dc.date.accessioned2017-08-23T09:34:20Z
dc.date.available2017-08-23T09:34:20Z
dc.date.created2017-05-30
dc.description.abstractGreater than 360 million persons will develop diabetes by the year 2030. New Insulins analogues, adjunctive non-insulin therapies such as use of incretin agents and SGLT-2 inhibitors are being actively pursued as a novel approach in diabetes therapy. Pluripotent stem cells in the production of pancreatic progenitor or insulin producing cells in also being researched towards the treatment of type 1 diabetes. Information technology has also enabled care providers enhance care process, and provide aid to diabetics .hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent30hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/243131
dc.language.isoenhu_HU
dc.subjecttrendshu_HU
dc.subjectDiabeteshu_HU
dc.subjectTreatmenthu_HU
dc.subjectNew trendshu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titleNew trends in the treatment of Diabeteshu_HU
Fájlok